| 2023-06-15 |
复牌提示：
2023-06-14 16:50:03 停牌，复牌日期 2023-06-14 17:55:00
|
| 2023-05-18 |
详情>>
股本变动：
变动后总股本596.26万股
变动原因 ▼▲
- 原因：
- Common Stock offered 1,408,384 shares by the company
|
| 2023-03-14 |
详情>>
业绩披露：
2023年中报每股收益-6.82美元,归母净利润-1492.23万美元,同比去年增长24.31%
|
| 2022-12-15 |
详情>>
业绩披露：
2023年一季报每股收益-4.5美元,归母净利润-806.14万美元,同比去年增长17.81%
|
| 2022-12-12 |
股东大会：
将于2022-12-30召开股东大会
会议内容 ▼▲
- 1.A pprove an amendment to our Articles of Incorporation, as amended to date, to increase the total number of shares of common stock, par value $0.0001 per share, authorized for issuance thereunder from 4,545,455 shares to 100,000,000 shares;
2.To consider any other business as may properly come before the Meeting or any postponement or adjournments thereof.
|
| 2022-11-09 |
详情>>
拆分方案：
每22.0000合并分成1.0000股
|
| 2022-10-31 |
详情>>
业绩披露：
2022年年报每股收益-0.87美元,归母净利润-3417.96万美元,同比去年增长24.33%
|
| 2022-06-14 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.66美元,归母净利润-2596.34万美元,同比去年增长22.20%
|
| 2022-05-31 |
股东大会：
将于2022-07-12召开股东大会
会议内容 ▼▲
- 1.to elect six directors to the Company’s Board of Directors, each to serve until our next annual meeting of stockholders or until his or her respective successor is duly elected and qualified;
2.to ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for our fiscal year ending July 31, 2022;
3.to transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2022-03-15 |
详情>>
业绩披露：
2022年中报每股收益-0.5美元,归母净利润-1971.6万美元,同比去年增长17.61%
|
| 2021-12-15 |
详情>>
业绩披露：
2022年一季报每股收益-0.25美元,归母净利润-980.86万美元,同比去年增长25.83%
|
| 2021-10-29 |
详情>>
业绩披露：
2021年年报每股收益-1.37美元,归母净利润-4516.77万美元,同比去年增长-6.9%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-11 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-1.08美元,归母净利润-3337.17万美元,同比去年增长-0.27%
|
| 2021-03-18 |
股东大会：
将于2021-04-29召开股东大会
会议内容 ▼▲
- 1.to elect nine directors to the Company’s Board of Directors to serve until our next annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.to ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for our fiscal year ending July 31, 2021;
3.to approve an amendment to our 2011 Equity Incentive Plan to increase the number of authorized shares issuable by 1,250,000 shares;
4.to transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2021-03-15 |
详情>>
业绩披露：
2021年中报每股收益-0.86美元,归母净利润-2392.94万美元,同比去年增长-2.29%
|
| 2020-12-11 |
详情>>
业绩披露：
2021年一季报每股收益-0.49美元,归母净利润-1322.53万美元,同比去年增长-35.5%
|
| 2020-04-30 |
股东大会：
将于2020-05-29召开股东大会
会议内容 ▼▲
- 1.to elect nine directors to the Company’s Board of Directors to serve until our next annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.to ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for our fiscal year ending July 31, 2020;
3.to approve an amendment to our Articles of Incorporation to increase our authorized share capital by 74,000,000 shares of common stock;
4.to approve certain amendments to our 2011 Stock Incentive Plan;
5.to approve the payment of a portion of 2019 annual bonuses to certain officers of the Company in shares of the Company’s common stock;
6.to approve, on an advisory basis, the compensation of the Company’s named executive officers;
7.to approve, on an advisory basis, the frequency of the advisory vote on compensation of our named executive officers;
8.to approve an amendment to our Articles of Incorporation to include a waiver of the duty of certain directors to present corporate opportunities to the Company;
9.to transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2019-07-12 |
股东大会：
将于2019-08-22召开股东大会
会议内容 ▼▲
- (1)to approve an amendment to our Articles of Incorporation to increase the number of authorized shares of common stock from 16,000,000 to 45,000,000;
(2)to approve an amendment to our Articles of Incorporation to authorize the Company to issue up to 5,000,000 shares of blank check preferred stock, par value $0.0001 per share, in one or more series as determined by the Board, with such rights, privileges, preferences and limitations as the Board may, in its sole discretion, determine;
(3)to transact such other business as may properly come before the Special Meeting and any adjournment or postponement thereof.
|
| 2019-05-21 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2018-11-08 |
股东大会：
将于2018-12-18召开股东大会
会议内容 ▼▲
- 1.to elect six directors to the Company’s Board of Directors to serve until our next annual meeting of stockholders or until their respective successors are duly elected and qualified;
2.to ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for our fiscal year ending July 31, 2019;
3.to approve an amendment to our Articles of Incorporation to authorize the Company to issue up to 10,000,000 shares of blank check preferred stock, par value $0.0001 per share, in one or more series as determined by the Board, with such rights, privileges, preferences and limitations as the Board may, in its sole discretion, determine;
4.to approve, on an advisory basis, the compensation of the Company’s named executive officers;
5.to transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2018-07-16 |
详情>>
内部人交易：
Bonstein Sara共交易2笔
|
| 2017-11-28 |
股东大会：
将于2018-01-12召开股东大会
会议内容 ▼▲
- (1)to elect five directors to the Company’s Board of Directors to serve until our next annual meeting of stockholders and until their respective successors are duly elected and qualified;
(2)to approve an amendment and restatement of the OncoSec Medical Incorporated 2011 Stock Incentive Plan (the “2011 Plan”), for the purpose of increasing the number of shares of our common stock reserved for issuance thereunder;
(3)to approve an amendment and restatement of the 2011 Plan, for the purpose of amending the provision therein that provides for certain annual and automatic increases in the shares of our common stock reserved for issuance thereunder;
(4)to approve stock option awards granted to Daniel J. O’Connor upon his appointment as our Chief Executive Officer;
(5)to ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for our fiscal year ending July 31, 2018;
(6)to transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2017-10-25 |
财报披露：
美东时间 2017-10-25 盘前发布财报
|
| 2016-10-27 |
股东大会：
将于2016-12-06召开股东大会
会议内容 ▼▲
- 1. to elect four directors to the Company’s Board of Directors to serve for a term of one year or until their successors are duly elected and qualified;
2. to approve an amendment and restatement of the Company’s 2011 Stock Incentive Plan to increase the number of shares reserved for issuance thereunder and to make certain other changes;
3. to ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for the fiscal year ending July 31, 2017;
4. to transact other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2015-10-21 |
股东大会：
将于2015-12-04召开股东大会
会议内容 ▼▲
- 1. to elect four directors to our Board of Directors to serve for a term of one year or until their successors are duly elected and qualified;
2. to approve the Company’s 2015 Employee Stock Purchase Plan;
3. to ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for the fiscal year ending July 31, 2016;
4. to approve, on an advisory basis, the compensation of the Company’s named executive officers;
5. to transact other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2015-06-17 |
股东大会：
将于2015-07-31召开股东大会
会议内容 ▼▲
- 1. to elect four directors to our Board of Directors to serve for a term of one year or until their successors are duly elected and qualified;
2. to ratify the appointment of Mayer Hoffman McCann P.C. as the Company's independent registered public accounting firm for the fiscal year ending July 31, 2015;
3. to amend the 2011 Stock Incentive Plan to increase the shares reserved for issuance thereunder and increase the annual per person limit on stock options, stock appreciation rights, restricted stock and restricted stock units that are intended to qualify for exclusion from the federal tax deduction limitation under Section 162(m) of the Internal Revenue Code;
4. to transact other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|